Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VKTX
VKTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VKTX News
Viking Therapeutics Advances Late-Stage Clinical Trials for VK2735
3d ago
stocktwits
VKTX Shares Surge as Retail Investors Flock to Obesity Treatment Investments
3d ago
stocktwits
Viking Therapeutics Completes Enrollment in Phase 3 Trial for VK2735 Obesity Drug
4d ago
stocktwits
Viking Therapeutics Completes Enrollment in VK2735 Clinical Trial
4d ago
PRnewswire
Viking Therapeutics Completes Enrollment for VK2735 Clinical Trial
4d ago
Newsfilter
Viking Therapeutics Poised for Potential Breakthrough in Obesity Drug Market
6d ago
Fool
Viking's VK2735 Drug Advances in Clinical Trials
6d ago
NASDAQ.COM
Comparative Analysis of Bitcoin and Viking Investments
Mar 22 2026
Fool
Investment Outlook for Viking Therapeutics and Bitcoin
Mar 22 2026
NASDAQ.COM
Novo Nordisk's High-Dose Wegovy Approved by FDA
Mar 19 2026
CNBC
Eli Lilly Leads U.S. Weight Loss Drug Market
Mar 18 2026
NASDAQ.COM
Eli Lilly vs. Viking Therapeutics in Weight Loss Drug Market
Mar 18 2026
Fool
ACT Capital Management Acquires New Position in Viking Therapeutics
Mar 16 2026
Fool
Viking Therapeutics Advances VK2735 Development Amid Mixed Trial Results
Mar 11 2026
NASDAQ.COM
Viking Therapeutics Shares Surge 16.5% Following Positive Developments
Mar 11 2026
Fool
Viking Therapeutics Executive Buys Shares Amid Obesity Pipeline Progress
Mar 11 2026
stocktwits
Show More News
